Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.
Saved in:
| Title: | Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy. |
|---|---|
| Authors: | Labrada M; Center of Molecular Immunology, Vaccine Department, 216 St and 15th Ave., Atabey, Playa, P. O. Box 16040, Havana, 11600, Cuba. mayrel@cim.sld.cu, Clavell M, Bebelagua Y, León Jd, Alonso DF, Gabri MR, Veloso RC, Vérez V, Fernández LE |
| Source: | Expert opinion on biological therapy [Expert Opin Biol Ther] 2010 Feb; Vol. 10 (2), pp. 153-62. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20088712 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Labrada+M%22">Labrada M</searchLink>; Center of Molecular Immunology, Vaccine Department, 216 St and 15th Ave., Atabey, Playa, P. O. Box 16040, Havana, 11600, Cuba. mayrel@cim.sld.cu<br /><searchLink fieldCode="AU" term="%22Clavell+M%22">Clavell M</searchLink><br /><searchLink fieldCode="AU" term="%22Bebelagua+Y%22">Bebelagua Y</searchLink><br /><searchLink fieldCode="AU" term="%22León+Jd%22">León Jd</searchLink><br /><searchLink fieldCode="AU" term="%22Alonso+DF%22">Alonso DF</searchLink><br /><searchLink fieldCode="AU" term="%22Gabri+MR%22">Gabri MR</searchLink><br /><searchLink fieldCode="AU" term="%22Veloso+RC%22">Veloso RC</searchLink><br /><searchLink fieldCode="AU" term="%22Vérez+V%22">Vérez V</searchLink><br /><searchLink fieldCode="AU" term="%22Fernández+LE%22">Fernández LE</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101125414%22">Expert opinion on biological therapy</searchLink> [Expert Opin Biol Ther] 2010 Feb; Vol. 10 (2), pp. 153-62. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101125414 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712598%22">14712598 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Biol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20088712 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1517/14712590903443084 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 153 Titles: – TitleFull: Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Labrada M – PersonEntity: Name: NameFull: Clavell M – PersonEntity: Name: NameFull: Bebelagua Y – PersonEntity: Name: NameFull: León Jd – PersonEntity: Name: NameFull: Alonso DF – PersonEntity: Name: NameFull: Gabri MR – PersonEntity: Name: NameFull: Veloso RC – PersonEntity: Name: NameFull: Vérez V – PersonEntity: Name: NameFull: Fernández LE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2010 Feb Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1744-7682 Numbering: – Type: volume Value: 10 – Type: issue Value: 2 Titles: – TitleFull: Expert opinion on biological therapy Type: main |
| ResultId | 1 |